a strong trendP=0.064
Patients with aGvHD showed a strong trend towards higher amounts of circulating naïve CD4+ and CD8+ T cells at 3 months after HSCT (25.9 vs. 3.1 x10 6 /L, P=0.064 and 31.5 vs. 1.2 x10 6 /L, p=0.052, respectively).
Patients with aGvHD showed a strong trend towards higher amounts of circulating naïve CD4+ and CD8+ T cells at 3 months after HSCT (25.9 vs. 3.1 x10 6 /L, P=0.064 and 31.5 vs. 1.2 x10 6 /L, p=0.052, respectively).
3.9 (1.2-8.2) pmol/L in non-cGvHD group), elevated PTH levels were noticed in 32.3% cGvHD patients comparing to 11.1% non-cGvHD patients, but the difference did not reach statistical significance (p=0.067).
However, the interrupted conditioning group showed a marginally significant tendency toward the higher incidence of chronic GVHD than the conventional conditioning group.
The history of chronic obstructive pulmonary disease before HSCT had a borderline significance.
There was no significant difference in OS, however a clear trend towards the FLAMSA cohort.
On multivariate analysis, AML in CR1 showed a trend towards improved RFS and OS, however, this was not statistically significant (HR 0.45 (0.20 - 1.04), P= 0.06 and HR 0.45 (0.20 - 1.02), P=0.056 respectively).
Although small numbers, we documented an interesting trend towards a decrease in PE-BSIs sustained by MDR-GNB.